Treatment of < em > Helicobacter pylori < /em > with potassium competitive acid blockers: A systematic review and meta-analysis
CONCLUSION: VPZ-based triple therapy outperformed conventional PPI-based triple therapy in eradicating H. pylori, positioning it as a highly effective first-line regimen. Additionally, TPZ-based triple therapy was non-inferior to classical PPI triple therapy.PMID:38577188 | PMC:PMC10989498 | DOI:10.3748/wjg.v30.i9.1213
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Joseph Edwin Kanu Jonathan Soldera Source Type: research
More News: Adenocarcinoma | Clinical Trials | Conferences | Databases & Libraries | Dyspepsia | Gastric (Stomach) Cancer | Gastritis | Gastroenterology | Helicobacter Pylori | Lymphoma | Peptic Ulcer | Potassium | Proton Pump Inhibitors PPIs | Study